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The effects of long-term treatment of rats with morphine sulfate were assessed upon the specific binding of 
[3H]clonidine to a2-adrenoceptors on neural membranes isolated from various brain areas and upon the function of 
presynaptic a2-adrenoceptors during field stimulation of hippocampal slices. Rats were injected with morphine every 8 
h for 14 days with doses which started at 10 mg/kg per injection i.p., and which increased every 3 days to a final dose 
of 100 mg/kg per injection on the last 2 days. At 8 and 32 h after the last injection the Bm~ , for [3H]clonidine binding 
to neural membranes from various brain areas was significantly decreased. At the same times, the fractional release of 
[3H]noradrenaline during field stimulation of hippocampal slices was increased and the sensitivity of the hippocampal 
slice to clonidine was reduced which indicated the development of a functional subsensitivity of the presynaptic 
a2-adrenoceptor. These changes in receptor function persisted at 72 h after the last morphine injection although at this 
time there were marked increases over control values in [3H]clonidine binding to membranes from all rat brain areas 
except the caudate nucleus. These findings suggest that changes in az-adrenoceptor number and function which 
develop during long-term morphine administration might play an important role in opiate dependence. 
a2-Adrenoceptors; Morphine dependence; Morphine withdrawal; Hippocampal slices; [3H]Clonidine binding; Brain; 
(Field stimulation, Rat) 
1. Introduction 
Morphine and related narcotic analgesics have 
long been known to modify noradrenergic nerve 
function in the rodent brain. Acute administration 
of morphine increased the turnover of dopamine 
(Clouet and Ratner, 1970) in the rat brain and 
noradrenaline and dopamine in the mouse brain 
(Smith et al., 1970; 1972). When mice were made 
dependent upon morphine, tolerance developed to 
these effects. After withdrawal of morphine from 
dependent mice, decreases in the turnover of 
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catecholamines occurred which followed the time 
course of the abstinence syndrome (Rosenman 
and Smith, 1972). The reasons for these changes in 
catecholamine turnover have never been eluci- 
dated. 
Presynaptic receptors play an important role in 
the regulation of noradrenaline release from neu- 
rons. A major mechanism which controls the re- 
lease of noradrenaline appears to be the feedback 
inhibition of release by noradrenaline located in 
the synaptic cleft. This inhibition is mediated by 
stimulation of the presynaptic a2-adrenoceptor 
(Langer, 1981; Starke, 1981). In recent years ra- 
dioligand binding techniques have been used to 
study az-adrenoceptors in the rat brain (for re- 
views see Bylund and U'Pr ichard ,  1983; 
U'Prichard, 1984). A number of investigators have 
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attempted to assess the status of c~2-adrenoceptors 
in the rat brain after acute and chronic morphine 
treatment by measuring the specific binding of 
[3H]clonidine to neural membranes isolated from 
various areas of the brain (Hamburg and Tallman, 
1981; Sethy and Harris, 1982; Smith et al., 1983; 
Vicentini et al., 1983). One study also assessed 
binding of [3H]clonidine to rat brain membranes 
during the morphine  abstinence syndrome 
(Ulibarri et al., 1987). The results of such investi- 
gations have been somewhat equivocal, and none 
of these studies attempted to relate changes in 
c~2-adrenoceptor density to changes in a2-adreno- 
ceptor function. 
A preliminary study has suggested that changes 
in c~2-adrenoceptor function occur in hippocampal 
slices from rats made dependent upon morphine 
(Moises et al., 1986). The purpose of the present 
study was to correlate changes in receptor number 
a n d / o r  affinity with changes in receptor function 
in rats treated for 1 or 14 days with increasing 
doses of morphine sulfate. To determine the den- 
sity of a2-adrenoceptors the specific binding of 
[3H]clonidine to neural membranes from various 
brain areas was measured. To assess presynaptic 
a 2 - a d r e n o c e p t o r  funct ion ,  the release of 
[3 H]noradrenaline from hippocampal slices during 
field stimulation was measured at various frequen- 
cies of stimulation and in the presence of cloni- 
dine, an az-adrenoceptor agonist. This study shows 
that with long-term administration of morphine 
both the number of az-adrenoceptors and the 
sensitivity of the presynaptic a2-adrenoceptor to 
clonidine decreases. Seventy-two hours after 
withdrawal of dependent rats from morphine, and 
at a time when the abstinence syndrome is no 
longer present, a marked increase in specific bind- 
ing of [3H]clonidine occurs in many brain areas 
which is not accompanied by an increase in sensi- 
tivity of the hippocampal slice preparation to 
clonidine. 
2. Materials and methods 
2.1. Animals and treatment schedule 
Male, Sprague-Dawley rats, weighing 180-220 g 
at the start of the study, were used. Animals were 
housed in groups of six and allowed free access to 
food and water. Rats were injected with saline or 
morphine sulfate i.p. every 8 h for 14 days. The 
dose of morphine started with 10 mg/kg,  3 times 
a day (t.i.d.) on the first day, was doubled every 
third day, and was maintained at 100 mg/kg  t.i.d. 
on the last two days of the schedule. Control 
animals were given i.p. injections of saline accord- 
ing to the same treatment schedule. 
2.2. Measurement of specific binding of [¢H]cloni- 
dine to neural membranes in rat brain homogenates 
Groups of six rats were used. At various inter- 
vals of time after the last injection of morphine or 
saline, the rats were killed by decapitation, their 
brains removed rapidly and placed in ice-cold 
Krebs physiological buffer solution and subse- 
quently dissected according to a modification of 
the method described by Glowinski and Iversen 
(1966). The Krebs buffer consisted of (raM): NaCI 
118; KC1 4.8; CaC12 1.3; KH2PO4 1.2; MgSO 4 
1.2; NaHCO 3 25; disodium EDTA 0.03; glucose 
10; ascorbic acid 0.06. The following regions were 
studied: hippocampus, amygdala, hypothalamus, 
parietal-occipital cortex, caudate nucleus, and an 
area of the brainstem which contained the locus 
coeruleus. 
The specific binding of [3H]clonidine to a 2- 
adrenoceptors in homogenates was measured as 
follows. Tissues pooled from the six rats were 
homogenized in 5 ml of ice-cold Tris-sucrose buffer 
(Tris-HCl 5 mM; sucrose 250 raM; MgC12 1 mM; 
pH 7.4). The homogenates were centrifuged at 
1 100 x g for 10 rain, and the supernatants were 
saved. The supernatants were next centrifuged at 
40000 X g for 10 min, and the pellet saved. The 
pellet was washed twice with 2 ml of fresh incuba- 
tion buffer (Tris-HCl 40 mM ; MgC12 10 mM; pH 
7.5) and recentrifuged at 40000 × g for 10 min. 
The final pellet was resuspended in an appropriate 
volume of Tris-incubation buffer. In equilibrium 
studies total [3H]clonidine binding was measured 
in 1 ml aliquots of the fresh membranes which 
were incubated in duplicate for 30 min at 25°C 
with 0.5-64 nM [3H]clonidine (specific activity 
32-45 mCi/mmol ,  N.E.N., Boston, MA). Non- 
specific binding was determined by adding un- 
labelled clonidine hydrochloride, 10 /tM (Boeh- 
ringer, Mannheim, W. Germany), as well as the 
radioligand to a second pair of incubates. Specific 
binding was defined as the difference between 
total and non-specific binding. In drug competi- 
tion studies, the neural membranes were in- 
cubated with [3H]clonidine at a concentration of 4 
nM in the presence of concentrations of morphine 
up to and including 100 ~tM. Incubations were 
terminated by rapid filtration under vacuum 
through Whatman G F / C  glass fiber filters and by 
washing with two 10 ml afiquots of Tris-incuba- 
tion buffer (25 ° C). After termination of the in- 
cubation, the glass fiber filters were air dried and 
then placed in glass scintillation vials and counted 
for radioactivity as described by Smith et al. (1972). 
A computerized program (EBDA, McPherson, 
1983) was used to develop preliminary estimates 
of the apparent dissociation constants (KD) and 
the maximum number of binding sites (Bronx) for 
the [3H]clonidine. The values obtained from this 
program were used as the preliminary estimates 
required for the non-linear regression analysis pro- 
gram devised by Munson and Rodbard (1980) 
which was used to develop the final values for K D 
and Bm~ x. Protein determinations were performed 
by the method of Lowry et al. (1951) in which 
bovine serum albumin was used as the protein 
standard. 
2.3. Field stimulated brain slices 
Rat brains were removed as described above. 
The hippocampi were isolated, and two transverse 
sections, 0.5 mm thick, were made perpendicular 
to the longitudinal axis of each hippocampus. The 
slices included the regio superior and the regio 
inferior of the dorsal hippocampus, the dentate 
gyrus and a portion of the subiculum. The four 
slices were equilibrated for 10 min in Krebs buffer 
saturated with 95% 02-5% CO 2 at 37 o C. After the 
period of equilibration, the slices were incubated 
with [3H]noradrenaline, 300 nM, for an additional 
15 min, washed twice with fresh Krebs buffer and 
transferred to 0.25 ml superfusion chambers. Each 
slice was lodged between two nylon mesh disks 
which in turn were sandwiched between two con- 
centrically coiled platinum electrodes. Each slice 
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was superfused at a rate of 0.5 ml per min for a 30 
rain equilibration period prior to the onset of field 
stimulation. 
Field stimulation consisted of trains of square- 
wave pulses (100 mA, 2 ms duration) at either 1 or 
4 Hz for 2 min periods. The first period of stimu- 
lation occurred immediately after the initial 30 
min superfusion period, and stimuli were applied 
at a frequency of 1 Hz. The second and all subse- 
quent periods of stimulation occurred at 16 min 
intervals during which stimuli were applied at a 
frequency of 4 Hz. There were nine stimulation 
periods in each experiment. The release of 
[3H]noradrenaline during the second stimulation 
period represented the baseline response. Two of 
each set of four slices were stimulated but did not 
receive any drug. For the other two slices drugs 
were introduced into the superfusion buffer im- 
mediately after the second and each subsequent 
period of stimulation. Drug concentrations were 
increased by approximately 3-fold increments in 
order to construct a complete concentration-effect 
curve. When one accounts for the time that it took 
for the drug to reach the superfusion chamber, 
each slice was equilibrated in the presence of each 
drug concentration for a period of 13.5 min after 
which the slice was stimulated for an additional 2 
min. 
Aliquots of the superfusate (2 ml) were col- 
lected at 4 min intervals with a LKB fraction 
collector and then transferred to glass scintillation 
vials. Immediately after the last aliquot of super- 
fusate was collected, the tissue slice was removed 
from the superfusion chamber, blotted, weighed, 
and homogenized in 0.05 ml NCS tissue solubi- 
lizer. Bray solution (15 ml) was added to each 
aliquot of superfusate and to the solubilized tis- 
sue, and the samples were counted as described 
above. Release of [3H]noradrenaline is expressed 
as the amount of labelled amine in each aliquot 
given as a percentage of the amount of labelled 
amine in the tissue immediately before collection 
of that aliquot. The stimulation-evoked release 
was calculated as the difference between the total 
release during the period of stimulation less the 
estimated basal release. Complete dose-response 
relationships were determined for clonidine, an 
a2-adrenoceptor agonist, with these preparations 
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in order to detect al terat ions in the sensitivity of 
presynapt ic  c~2-adrenoceptors. ECs0s were com- 
puted  by the method of probi t  analysis described 
by Golds te in  (1964), All results are expressed as 
mean  values + S.E.M. Statistical significance was 
evaluated with Student ' s  t-test. 
3 .  R e s u l t s  
3.1. Binding of [3H]clonidine to neural membranes 
High affinity b ind ing  to neural  membranes  was 
rapid, saturable and  reversible by clonidine,  10 -5 
M. The regional d is t r ibut ion  of specific b ind ing  in 
the rat bra in  was uneven  and  similar to that 
reported previously (Smith et al., 1981; fig. 1). The 
highest degree of b ind ing  (in f m o l / m g  protein)  
occurred with membranes  isolated from the 
amygdala  (162 + 12, n = 12), hypotha lamus  (147 
_+ 7, n = 13) and parietal-occipital  cortex (138 + 6, 
n = 12); in termediate  values were obta ined  with 
membranes  from the h ippocampus  (97 + 3, n = 
12); and the lowest values with membranes  from 
the bra ins tem (69 ___ 5, n = 11) and  caudate nucleus 
(62 + 3, n = 10). Analysis  with the M u n s o n  and  
Rodba r d  (1981) program, L I G A N D ,  indicated that 
the data  fitted best a model  based on a single 
popula t ion  of b ind ing  sites. KDS ranged from 
2.7 + 0.3 n M  (n = 10) for b ind ing  to membranes  
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Fig. 1. Binding of [3H]clonidine to neural membranes isolated from various areas of the rat brain. Rats were treated with saline (C) 
or with increasing doses of morphine as described in Methods. The maximum number of binding sites (Brnax) were measured at 8, 32 
or 72 h after the last injection of morphine. In some experiments (A) rats were treated with morphine, 10 mg/kg per injection, every 
8 h for 1 day and killed 8 h after the last injection. Each value represents the mean of 3-8 determinations. Vertical bars represent the 
S.E,M. * P < 0.05, * * P < 0.005, * * * P < 0.0005. Ordinate: Bma x (fmol/mg protein). 
from caudate nucleus to 4.5 + 0.9 nM (n = 13) for 
membranes from the hypothalamus. None of the 
treatments caused statistically significant changes 
in KDs for binding of [3H]clonidine to mem- 
branes isolated from any brain area. 
When measured 8 h after the last injection of 
morphine, the specific binding of [3 H]clonidine to 
.neural membranes isolated from rats treated for 
14 days was significantly decreased (fig. 1). At this 
time the rats were highly dependent and signs of 
the morphine-abstinence syndrome had not yet 
developed. When compared to controls treated for 
14 days with saline, the following decreases in 
binding were observed: amygdala ( - 25 _+ 4%, n = 
6, P < 0.005), parietal-occipital cortex ( - 26 +_ 3%, 
n = 8, P < 0.005), hypothalamus ( -  23 +_ 4%, n = 
6, P < 0.05), hippocampus ( - 2 6  +_ 3%, n = 7, P < 
0.0005) and caudate nucleus ( - 3 4  +_ 4%, n = 3, 
P < 0.005). In contrast, specific binding of 
[3H]clonidine to neural membranes from the 
brainstem was slightly but not significantly in- 
creased (+3%,  n = 6). 
Although still depressed at 32 h after the last 
morphine injection, the specific binding of 
[3H]clonidine started to return toward normal val- 
ues for membranes isolated from the cortex, hip- 
pocampus, hypothalamus and amygdala (fig. 1). 
At this time all dependent animals demonstrated a 
full abstinence syndrome and experienced a 
marked weight loss (mean loss 28.3 _+ 0.4%, n = 
30). When compared to saline-treated controls the 
following decreases were observed: parietal-oc- 
cipital cortex ( -  21 ___ 6%, n = 5, P < 0.05), hippo- 
campus ( -  19 + 5%, n = 5, P < 0.005) and hypo- 
thalamus ( -  17 + 6%, n = 3, P < 0.05). Specific bi- 
nding of [3H]clonidine was not significantly dif- 
ferent from control values for the amygdala ( - 9  
+ 5%, n = 3), caudate nucleus ( + 6  + 15%, n = 3) 
and brainstem ( +  29 +_ 2%, n = 3). 
Seventy-two hours after the last morphine in- 
jection marked increases occurred in the specific 
binding of [3H]clonidine to membranes isolated 
from the amygdala, parietal-occipital cortex, hip- 
pocampus,  hypothalamus and brainstem of 
morphine-treated rats (fig. 1). When compared to 
saline-treated controls, the following increases oc- 
curred: amygdala ( +  66 _+ 12%, n = 6, P < 0.005), 
parietal-occipital cortex ( + 3 7  + 11%, n = 5, P < 
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0.005), hippocampus (+46+_8%,  n - - 6 ,  P <  
0.005), hypothalamus ( + 23 _+ 9%, n = 6, P < 0.05), 
and brainstem ( + 6 4  + 15%, n = 5, P < 0.0005). 
Only binding to caudate membranes remained 
unchanged ( + 6 +_ 6%, n = 4). 
Short-term treatment of rats with morphine, 10 
m g / k g  t.i.d, for 1 day, did not alter the specific 
binding of [3H]clonidine to membranes from any 
brain area. After a single day of morphine admin- 
istration the Bm~s ( f m o l / m g  protein) and KDs 
(nM) were as follows: amydala (188 _+ 17, 2.5 + 
0.31, n = 4), parietal-occipital cortex (121 _+ 4, 2.5 
+ 0.5, n = 3), h ippocampus (84 _+ 5, 3.3 _+ 0.4), hy- 
pothalamus (136 _+ 14, 4.0 _+ 0.8, n = 5), brainstem 
(80 _+ 4, 2.4 _+ 0.3, n = 4) and caudate nucleus (64 
+ 6, 3.0 +_ 0.5, n = 4). Furthermore, in equilibrium 
experiments, morphine, when added in vitro in 
concentrations up to and including 100 btM, failed 
to displace [3H]clonidine from membranes iso- 
lated from the hippocampus or from the parietal- 
occipital cortex. 
3.2. Field stimulation of rat hippocampal slices 
When rat hippocampal  slices from saline-treated 
controls, prelabelled with [3H]noradrenaline, were 
stimulated at 1 Hz ($1) for 2 rain, 0.48 +__ 0.06% of 
the labelled amine was released in excess of the 
spontaneous efflux of tritium (table 1). Pre- 
liminary experiments in which [3H]noradrenaline 
was separated from its metabolites on Dowex 
columns indicated that greater than 90% of the 
released tr i t ium represented  unmetabol ized  
[3H]noradrenal ine .  When  s t imulated at a 
frequency of 4 Hz ($2), the fractional release was 
1.21+0.15% ( n =  11) and the $2/S 1 ratio was 
2.58 + 0.10 (table 1). 
When measured 8 h after the last injection of 
morphine, the fractional release during both S 1 
( + 62.5%, n = 6, P < 0.02) and $2 ( + 29.8%, n = 6) 
was increased although the increase during S 2 did 
not reach statistical significance. The S2/Sa ratio 
was significantly decreased ( - 1 9 % ,  n = 6, P < 
0.02) which indicated a greater increase in release 
at the lower frequency of stimulation than at the 
higher. The fractional release of [3H]noradrenaline 
was increased further during both S 1 (+87.5%, 
n = 4, P < 0.002) and $2 ( + 60.3%, n = 4, P < 0.01) 
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32 h after the last injection of morphine, and the 
82/S 1 ratio was still decreased ( - 16.7%, P < 0.02). 
The fractional release of [3H]noradrenaline re- 
mained increased during both $1 ( +  81.3%, n = 5, 
P < 0.001) and S 2 (+55.4%, n = 5, P < 0.01), and 
the $2/S 1 ratio remained depressed ( -  15.9%, P < 
0.02) at 72 h after the last injection of morphine. 
These results are consistent with a subsensitivity 
of the a2-adrenoceptor at all three time intervals 
after the last administration of morphine to de- 
pendent rats. 
3.3. Clonidine concentration-effect curves 
Further evidence for a subsensitivity of c~ 2- 
adrenoceptors after chronic morphine administra- 
tion was manifested by changes in the response of 
the hippocampal slices to clonidine. The ECs0 for 
inhibition by clonidine of [3H]noradrenaline re- 
lease from hippocampal slices from saline-treated 
rats was 4.7 + 0.6 nM (n = 11, table 1). The value 
was similar to the K D for [3H]clonidine binding 
to neural membranes from the normal rat hippo- 
campus (3.7 + 0.5 nM, n = 12). Eight hours after 
the last injection of morphine to dependent rats, 
there was a 10-fold shift to the right in the cloni- 
TABLE 1 
Fractional release of [3H]norepinephrine during field stimula- 
tion of hippocampal slices from control and morphine-treated 
rats. Sensitivity to clonidine. Fractional  release of 
[3H]norepinephrine at 1 Hz (Sx) or 4 Hz ($2) is expressed as a 
percent of the total [3H]norepinephrine in the tissue at the 
onset of the period of stimulation. Rats were treated for 14 
days with increasing doses of morphine as described in Meth- 
ods. Each value represents the mean of 4-11 determinations_+ 
S.E.M. 
Condition S 1 S 2 $2/S  1 Clonidine 
(1 Hz) (4 Hz) Ratio ECs0 (nM) 
Control 0.48 1.21 2.58 4.7 
_+0.06 _+0.15 _+ 0.10 _+0.6 
Withdrawn 
8 h 0.78 " 1.57 2.09 " 47.2 " 
_+0.14 _+0.16 _+0.19 _+5.3 
32 h 0.90 a 1.94 b 2.15 a 9.2 b 
_+0.09 +0.21 +0.06 -+1.9 
72 h 0.87 e 1.88 b 2.17 a 12.9 c 
_+0.06 _+0.10 _+0.09 _+3.5 
" P < 0 .02 ,  b P < 0 .01 ,  c P < 0 . 0 0 5 ,  d P < 0 . 0 0 2 ,  e P < 0 . 0 0 1 .  
% INHIBITION 
90 '  
6 0  
: I 
/ "  2 
a0 ; ,} 
i s :  ;~ 
o 
- 9  - 8  - 7  - 6  
CLONIDINE (LOG MOLAR CONCENTRATION) 
Fig. 2. Inhibition of the release of [3H]noradrenaline by cloni- 
dine during field stimulation of hippocampal slices from saline 
or morphine-treated rats. Abscissa, molar concentration of 
clonidine in perfusate. Ordinate, fractional release of 
[3H]noradrenaline expressed as a percent of release prior to 
administration of clonidine. Rats were treated for 14 days with 
increasing doses of morphine as described in Methods. De- 
terminations were made on hippocampal slices from 11 saline 
control rats (solid circles), and at 8 h (open circles, n = 7), 32 h 
(solid triangles, n = 4) and 72 h (open triangles, n = 4) after 
the last injection of morphine. Each point represents the mean 
value. Vertical bars represent the S.E.M. 
dine concentration effect curve (fig. 2) as indi- 
cated by a significant increase in the ECs0 for 
clonidine (47.2 + 5.3, n = 6, P < 0.02, table 1). At 
both 32 and 72 h after the last morphine injection, 
the clonidine concentration-effect curves remained 
shifted to the right (fig. 2, table 1), although to a 
lesser extent than observed at 8 h. At none of the 
time intervals were the maximum responses to 
clonidine significantly altered. 
4. D i s c u s s i o n  
The binding of [3H]clonidine to neural mem- 
branes isolated from the rat brain has been used 
extensively to evaluate the status of a2-adrenocep- 
tors in animals treated chronically with morphine. 
The present study demonstrates significant de- 
creases in the density of c~2-adrenoceptors on neu- 
ral membranes  isolated from the amygdala, oc- 
cipital-parietal cortex, hippocampus,  hypothala- 
mus and caudate nucleus 8 and 32 h after the last 
injection of morphine to dependent rats and large 
increases in the density of otz-adrenoceptors 72 h 
after the last morphine injection. Previous studies 
of changes in [3H]clonidine binding to rat neural 
membranes after 'chronic' morphine treatment 
have reported highly divergent results. Hamburg 
and Tallman (1980) found that implantation of 
rats with 75 mg morphine pellets for 3 days re- 
sulted in increased binding of [3H]clonidine to 
membranes isolated from cerebral cortex and 
brainstem. Smith et al. (1983) found decreases in 
the specific binding of [3H]clonidine to neural 
membranes from various brain areas isolated from 
rats injected with increasing doses of morphine for 
14 days. With a treatment protocol similar to that 
of Hamburg and Tallman (1980), Vincentini et al. 
(1983) found to change in the binding of 
[3H]clonidine to rat cortical membranes. Sethy 
and Harris (1982) also found no change in the 
binding of [3H]clonidine to neural membranes 
when rats were infused i.v. with morphine over a 
period of 10 days. When rats were given increas- 
ing concentrations of morphine in their drinking 
water for various periods of time, Ulibarri et al. 
(1987) found increases, decreases or no changes in 
the binding of [3H]clonidine to neural membranes 
from various brain areas. Factors which might 
underlie these differences include the dose and 
dosage form of the morphine which was adminis- 
tered, the frequency of morphine administration 
and the area of the brain which was studied. Such 
factors previously have been shown to be ex- 
tremely important in determining the direction of 
change in az-adrenoceptor density after the ad- 
ministration of tricyclic antidepressants (Smith and 
Hollingsworth, 1983; 1984). 
Recently changes in the density of cortical and 
hippocampal fl-adrenoceptors were found to be 
well-correlated with changes in the sensitivity of 
cortical and hippocampal neurons to fl-adrenergic 
stimulation at various intervals of time after the 
last injection of morphine to rats treated chroni- 
cally according to a schedule which was the same 
as that used in the present study (Moises and 
Smith, 1984; 1987; in press). However, the func- 
tional significance of changes in a2-adrenoceptor 
density after chronic morphine administration has 
not been elucidated previously. Most electrophysi- 
ological studies of ct2-adrenoceptor function after 
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chronic morphine administration have been per- 
formed upon cells located in the rat locus 
coeruleus. In these studies schedules of morphine 
administration which result in tolerance to opiates 
failed to modify cellular responses to a2-adreno- 
ceptor agonists such as clonidine (Aghajanian, 
1978; Andrade et al., 1983; Christie et al., 1987). 
Such observations are consistent with the present 
study in which no changes in a2-adrenoceptor 
density were found with neural membranes iso- 
lated from the region of the brainstem which 
contains the locus coeruleus at either 8 or 32 h 
after the last injection of morphine to chronically 
treated animals. 
In the present study a good correlation was 
found between changes in a2-adrenoceptor density 
in the hippocampus and changes in the sensitivity 
of presynaptic a2-adrenoceptors to clonidine dur- 
ing field stimulation of hippocampal slices when 
studied at either 8 or 32 h after the last injection 
of morphine to rats treated for 14 days. The 
decrease in a2-adrenoceptor sensitivity was associ- 
ated with an increase in the fractional release of 
[3H]noradrenaline during field stimulation, espe- 
cially at the lower frequency (1 Hz) of stimulation. 
This receptor subsensitivity could account for in- 
creased release of noradrenaline which has been 
associated with the opiate withdrawal syndrome 
(Swann et al., 1983; Charney et al., 1984). 
In contrast to the earlier time intervals, at 72 h 
after the last injection of morphine to the depen- 
dent rats, a marked increase in a2-adrenoceptor 
number was found with membranes isolated from 
all brain areas except the caudate nucleus. Ulibarri 
et al. (1987) reported similar increases in a 2- 
adrenoceptor density in rat hypothalamus, cerebral 
cortex and brainstem during withdrawal. How- 
ever, in the present study, these increases in a 2- 
adrenoceptor density in the hippocampus were not 
accompanied by a similar increase in presynaptic 
receptor sensitivity to clonidine. These findings do 
not support the suggestion that there exists a 
supersensitivity of a2-adrenoceptors in the brains 
of dependent subjects during withdrawal (Garcia- 
Sevilla et al., 1985; 1987). In fact, az-adrenoce p- 
tors remained subsensitive to clonidine at 72 h 
after the last injection, a time when all signs of 
withdrawal had subsided completely. Thus, this 
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study shows that the changes in the size of the 
total population of a2-adrenoceptors on neural 
membranes isolated from the brain are not neces- 
sarily correlated with changes in the function of 
presynaptic a2-adrenoceptors. 
Since a large proportion of c~2-adrenoceptor 
binding sites in the rat brain are postsynaptic 
rather than presynaptic (Smith and Hollingsworth, 
1983; U'Prichard, 1984), it is possible that the 
increase in az-adrenoceptor density seen at 72 h 
after the last morphine injection to dependent rats 
represents an increase in postjunctional c~2-adren- 
oceptors. An alternative explanation of the in- 
crease in a2-adrenoceptor density combined with a 
decrease in receptor function is that although the 
number of receptors is increased, fewer receptors 
are coupled so that receptor occupation results in 
a diminished inhibition of [3H]noradrenaline re- 
lease. The basis and significance of these changes 
in receptor density and function remain to be 
elucidated. 
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